Press Releases INVO Fertility, Inc.

Equities

IVF

US44984F6097

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 16/07/2025 BST			5-day change	1st Jan Change
0.8199 ^USD	+2.24%		-4.55%	-91.56%

07-09	INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing	CI
06-30	Invo Fertility, Inc. Adds Platelet-Rich Plasma Therapy Capabilities At Wisconsin Fertility Institute	CI

Press Releases

INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing	07-09	AQ
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute	06-30	AQ
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent	06-25	AQ
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time	06-20	AQ
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute	06-18	AQ
INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025	06-17	AQ
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025	06-16	AQ
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025	05-27	AQ
INVO Fertility Announces First Quarter 2025 Financial Results	05-20	AQ
Commodity Supercycle Spotlight: Power Metallic (TSXV: PNPN \| OTCQB: PNPNF) Expands High-Grade Copper-Gold Zone-More Stocks Under $2 Gaining Traction	05-01	AQ
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA	04-30	AQ
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”	04-24	AQ
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”	04-15	AQ
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025	03-13	AQ
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment	02-25	AQ
NAYA Biosciences Announces Nomination of New Board Members	02-19	AQ
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering	01-13	AQ
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody	01-06	AQ
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)	31/10/24	AQ
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma	24/10/24	AQ
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences	21/10/24	AQ
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) Form 8 K	15/10/24	PU
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)	14/10/24	AQ
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA	14/08/24	AQ
INVO Reports Record First Quarter 2024 Financial Results	15/05/24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases INVO Fertility, Inc.

Equities

IVF

US44984F6097

Medical Equipment, Supplies & Distribution

Press Releases

Filters